| 6.61 Data as of Jun 19 | -0.10 / -1.49%Today’s Change | 5.55 Today|||52-Week Range 11.84 | -- Year-to-Date |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $98.5M |
Company Description
LipoScience, Inc. operates as an vitro diagnostic company, which provides advanced patient care for the patients who are suffering from cardiovascular, metabolic and other related diseases. It develops proprietary tests based on Nuclear Magnetic Resonance, an information-rich technology that produces a digital representation of the molecules present in a simple blood sample. The NMR LipoProfile test measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information to manage the risk of heart disease. The company was founded by James D. Otvos on June 14, 1994 and is headquartered in Raleigh, NC.
Employees

Shareholders
| Other institutional | 35.84% |
| Mutual fund holders | 3.22% |
| Individual stakeholders | 24.79% |
Top Executives
| Richard O. Brajer, MBA | President, Chief Executive Officer & Director |
| Timothy J. Fischer | Chief Operating Officer |
| Lucy G. Martindale, MBA | Chief Financial Officer & Executive Vice President |
| Robert M. Honigberg, MD, MBA | Chief Medical Officer & VP-Medical Affairs |
| James D. Otvos, PhD | Chief Scientific Officer & Executive VP |